Jan Pitha1,2, Rudolf Poledne3. 1. Center for Experimental Research, Prague, Czech Republic. japi@ikem.cz. 2. Clinic of Cardiology, Laboratory for Atherosclerosis Research, Center for Experimental Research, Institute for Clinical and Experimental Medicine, Videnska 1958/9, Praha 4, 140 21, Prague, Czech Republic. japi@ikem.cz. 3. Clinic of Cardiology, Laboratory for Atherosclerosis Research, Center for Experimental Research, Institute for Clinical and Experimental Medicine, Videnska 1958/9, Praha 4, 140 21, Prague, Czech Republic.
Abstract
PURPOSE OF REVIEW: To discuss the effect of fish oils on dyslipidemias and associated disorders. RECENT FINDINGS: The most important lipid effect of fish oils is reducing plasma triglycerides and the main potential protection against cardiovascular events is very probably mediated also through other mechanisms including anti-inflammatory ones. The best results are available for omega-3 fatty acids, namely, eicosapentaenoic acid. Less evidence is available for the impact of ω-3 fatty acids on liver steatosis/steatohepatitis and acute pancreatitis. In addition, particular fish oils have variable content of saturated and unsaturated fatty acids with different anti- or pro-oxidative potential, and the suboptimal ratio of these compounds could attenuate or abolish their beneficial properties. Fish products with optimal proportion of fatty acids, particularly high content of eicosapentaenoic acid, could be recommended to patients with dyslipidemias, especially to those at high risk for cardiovascular disease; less evidence is available for liver disease and acute pancreatitis.
PURPOSE OF REVIEW: To discuss the effect of fish oils on dyslipidemias and associated disorders. RECENT FINDINGS: The most important lipid effect of fish oils is reducing plasma triglycerides and the main potential protection against cardiovascular events is very probably mediated also through other mechanisms including anti-inflammatory ones. The best results are available for omega-3 fatty acids, namely, eicosapentaenoic acid. Less evidence is available for the impact of ω-3 fatty acids on liver steatosis/steatohepatitis and acute pancreatitis. In addition, particular fish oils have variable content of saturated and unsaturated fatty acids with different anti- or pro-oxidative potential, and the suboptimal ratio of these compounds could attenuate or abolish their beneficial properties. Fish products with optimal proportion of fatty acids, particularly high content of eicosapentaenoic acid, could be recommended to patients with dyslipidemias, especially to those at high risk for cardiovascular disease; less evidence is available for liver disease and acute pancreatitis.
Entities:
Keywords:
Dyslipidemia; Eicosapentaenoic acid; Fish oils; Omega-3 fatty acids
Authors: Michel R Langlois; M John Chapman; Christa Cobbaert; Samia Mora; Alan T Remaley; Emilio Ros; Gerald F Watts; Jan Borén; Hannsjörg Baum; Eric Bruckert; Alberico Catapano; Olivier S Descamps; Arnold von Eckardstein; Pia R Kamstrup; Genovefa Kolovou; Florian Kronenberg; Anne Langsted; Kari Pulkki; Nader Rifai; Grazyna Sypniewska; Olov Wiklund; Børge G Nordestgaard Journal: Clin Chem Date: 2018-05-14 Impact factor: 8.327
Authors: Eric B Rimm; Lawrence J Appel; Stephanie E Chiuve; Luc Djoussé; Mary B Engler; Penny M Kris-Etherton; Dariush Mozaffarian; David S Siscovick; Alice H Lichtenstein Journal: Circulation Date: 2018-05-17 Impact factor: 29.690
Authors: Giovanni Annuzzi; Angela A Rivellese; Hong Wang; Lidia Patti; Olga Vaccaro; Gabriele Riccardi; Sven Oe Ebbesson; Anthony G Comuzzie; Jason G Umans; Barbara V Howard Journal: Am J Clin Nutr Date: 2012-05-09 Impact factor: 7.045